Effect of mindfulness-based mind-body therapies in patients with non-specific low back pain—A network meta-analysis of randomized controlled trials
Although mindfulness-based mind-body therapy (MBMBT) is an effective non-surgical treatment for patients with non-specific low back pain (NLBP), the best MBMBT mode of treatment for NLBP patients has not been identified. Therefore, a network meta-analysis (NMA) was conducted to compare the effects of different MBMBTs in the treatment of NLBP patients.
MethodsPubMed, EMBASE, Cochrane Central Register of Controlled Trials, and Web of Science databases were searched for randomized controlled trials (RCTs) applying MBMBT for the treatment of NLBP patients, with all of the searches ranging from the time of database creation to January 2023. After 2 researchers independently screened the literature, extracted information, and evaluated the risks of biases in the included studies, the data were analyzed by using Stata 16.0 software.
ResultsA total of 46 RCTs were included, including 3,886 NLBP patients and 9 MBMBT (Yoga, Ayurvedic Massage, Pilates, Craniosacral Therapy, Meditation, Meditation + Yoga, Qigong, Tai Chi, and Dance). The results of the NMA showed that Craniosacral Therapy [surface under the cumulative ranking (SUCRA): 99.2 and 99.5%] ranked the highest in terms of improving pain and disability, followed by Other Manipulations (SUCRA: 80.6 and 90.8%) and Pilates (SUCRA: 54.5 and 71.2%). In terms of improving physical health, Craniosacral Therapy (SUCRA: 100%) ranked the highest, followed by Pilates (SUCRA: 72.3%) and Meditation (SUCRA: 55.9%). In terms of improving mental health, Craniosacral Therapy (SUCRA: 100%) ranked the highest, followed by Meditation (SUCRA: 70.7%) and Pilates (SUCRA: 63.2%). However, in terms of improving pain, physical health, and mental health, Usual Care (SUCRA: 7.0, 14.2, and 11.8%, respectively) ranked lowest. Moreover, in terms of improving disability, Dance (SUCRA: 11.3%) ranked lowest.
ConclusionThis NMA shows that Craniosacral Therapy may be the most effective MBMBT in treating NLBP patients and deserves to be promoted for clinical use.
Systematic review registrationhttps://www.crd.york.ac.uk/PROSPERO/, PROSPERO [CRD42023389369].
CITE THIS COLLECTION
REFERENCES
- https://doi.org//10.4103/0973-6131.158476
- https://doi.org//10.1016/j.jos.2020.10.026
- https://doi.org//10.1136/bmj.i6748
- https://doi.org//10.5604/15093492.1135120
- https://doi.org//10.1016/S1529-9430%2803%2900152-9
- https://doi.org//10.1002/ejp.529
- https://doi.org//10.1089/acm.2016.0068
- https://doi.org//10.1016/j.jpain.2022.09.014
- https://doi.org//10.1001/jama.2016.2323
- https://doi.org//10.1016/S0140-6736%2818%2930725-6
- https://doi.org//10.1017/S1092852920001480
- https://doi.org//10.1016/j.ctcp.2010.05.007
- https://doi.org//10.1177/0269215518768393
- https://doi.org//10.1002/14651858.ED000142
SHARE
Usage metrics
